EEG Predictive Indices for Suicidal Risk in Antidepressant Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antidepressant treatments lack effective methods to identify individuals at risk for suicidal thoughts and actions, particularly in adolescents, where pharmacological interventions may increase the risk of suicidal behavior, and existing EEG studies primarily focus on post-suicide attempts rather than predictive analysis.
Innovation Solution
A system and method that derive and compute features and indices from biopotential signals, specifically EEG power spectrum and time domain values, to predict the likelihood of suicidal thoughts and actions before and during treatment, using a Data Acquisition Unit and Data Computation Unit to process EEG signals and calculate predictive indices such as Pred2 and asymmetry features.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological treatment is applied to depressed subjects, then treatment effectiveness is improved, but the risk of suicidal behavior increases in adolescents
Solution Approach 1:
The system performs preliminary EEG assessment before and during antidepressant treatment to identify individuals at risk for suicidal behavior. By computing predictive indices from baseline EEG recordings, the system enables clinicians to proactively monitor and adjust treatment plans before adverse events occur, rather than reacting after suicidal behavior emerges.
Solution Approach 2:
The system implements continuous feedback monitoring through repeated EEG assessments during treatment. The predictive indices are recalculated based on changes in EEG patterns over time, providing ongoing information about treatment response and emerging risk, allowing dynamic adjustment of treatment to maintain effectiveness while minimizing harmful effects.
2Measurement precision
If EEG assessment is performed to predict suicidal risk, then identification of at-risk individuals is improved, but measurement precision is insufficient in existing studies
Solution Approach 1:
The system transforms raw EEG signals into multiple derived parameters including power spectrum values across different frequency bands (delta, theta, alpha, beta, gamma), time-domain features, and composite predictive indices. This multi-parameter approach captures complex neural patterns associated with suicidal risk more comprehensively than single-measure assessments.
Solution Approach 2:
The system combines multiple EEG features and predictive indices into a comprehensive risk assessment model. By integrating information from different frequency bands, time domains, and computational features, the system creates a composite predictive measure that achieves both high measurement precision and reliability in identifying at-risk individuals.
3Measurement precision
If comprehensive EEG analysis is performed to predict adverse events, then prediction accuracy is improved, but device complexity increases
Solution Approach 1:
The system divides the EEG analysis into distinct modular components: signal acquisition, preprocessing and filtering, power spectrum analysis across frequency bands, time-domain feature extraction, and predictive index computation. Each module processes specific aspects of the EEG signal independently, making the overall complex system more manageable and interpretable.
Solution Approach 2:
The system introduces computational intermediaries that transform raw EEG data into meaningful predictive indices. These intermediate calculations include power spectrum transformations, feature extraction algorithms, and risk score computations that bridge the gap between complex neural signals and clinically actionable predictions, simplifying the interpretation process.
Data Source
AI summary
The present invention is a system and method of deriving and computing features and indices that predict the likelihood of psychological and neurological adverse events such as suicidal thoughts and/or actions. The method of the present invention further predicts the likelihood of suicidal thoughts and/or actions prior to and or during treatment for psychological disease. To obtain such features and indices, power spectrum and time domain values are derived from biopotential signals acquired from the subject being tested. The system and method identify people who are likely to experience changing, especially worsening, symptoms of psychological and neurological adverse events such as suicidal thoughts or actions and who therefore may be at risk (e.g. suicide).